Hosotani R - Search Results

1

A novel synthetic Arg-Gly-Asp-containing peptide cyclo(-RGDf==V-) is the potent inhibitor of angiogenesis.

Kawaguchi M, Hosotani R, Ohishi S, Fujii N, Tulachan SS, Koizumi M, Toyoda E, Masui T, Nakajima S, Tsuji S, Ida J, Fujimoto K, Wada M, Doi R, Imamura M. Kawaguchi M, et al. Among authors: hosotani r. Biochem Biophys Res Commun. 2001 Nov 2;288(3):711-7. doi: 10.1006/bbrc.2001.5809. Biochem Biophys Res Commun. 2001. PMID: 11676501

2

Trojan p16 peptide suppresses pancreatic cancer growth and prolongs survival in mice.

Hosotani R, Miyamoto Y, Fujimoto K, Doi R, Otaka A, Fujii N, Imamura M. Hosotani R, et al. Clin Cancer Res. 2002 Apr;8(4):1271-6. Clin Cancer Res. 2002. PMID: 11948142

3

Expression of integrin alphaVbeta3 in pancreatic carcinoma: relation to MMP-2 activation and lymph node metastasis.

Hosotani R, Kawaguchi M, Masui T, Koshiba T, Ida J, Fujimoto K, Wada M, Doi R, Imamura M. Hosotani R, et al. Pancreas. 2002 Aug;25(2):e30-5. doi: 10.1097/00006676-200208000-00021. Pancreas. 2002. PMID: 12142752

4

Expression of IL-6 receptor in pancreatic cancer: involvement in VEGF induction.

Masui T, Hosotani R, Doi R, Miyamoto Y, Tsuji S, Nakajima S, Kobayashi H, Koizumi M, Toyoda E, Tulachan SS, Imamura M. Masui T, et al. Among authors: hosotani r. Anticancer Res. 2002 Nov-Dec;22(6C):4093-100. Anticancer Res. 2002. PMID: 12553038

5

Endogenous decoy receptor 3 blocks the growth inhibition signals mediated by Fas ligand in human pancreatic adenocarcinoma.

Tsuji S, Hosotani R, Yonehara S, Masui T, Tulachan SS, Nakajima S, Kobayashi H, Koizumi M, Toyoda E, Ito D, Kami K, Mori T, Fujimoto K, Doi R, Imamura M. Tsuji S, et al. Among authors: hosotani r. Int J Cancer. 2003 Aug 10;106(1):17-25. doi: 10.1002/ijc.11170. Int J Cancer. 2003. PMID: 12794752

6

Bcl-XL antisense oligonucleotides coupled with antennapedia enhances radiation-induced apoptosis in pancreatic cancer.

Masui T, Hosotani R, Ito D, Kami K, Koizumi M, Mori T, Toyoda E, Nakajima S, Miyamoto Y, Fujimoto K, Doi R. Masui T, et al. Among authors: hosotani r. Surgery. 2006 Aug;140(2):149-60. doi: 10.1016/j.surg.2006.03.014. Surgery. 2006. PMID: 16904964

7

Receptor binding of cholecystokinin analogues in isolated rat pancreatic acini.

Doi R, Hosotani R, Inoue K, Fujii N, Yajima H, Rayford PL, Tobe T. Doi R, et al. Among authors: hosotani r. Biochem Biophys Res Commun. 1990 Jan 15;166(1):286-92. doi: 10.1016/0006-291x(90)91943-m. Biochem Biophys Res Commun. 1990. PMID: 2302208

8

An exogenous cdk inhibitor, butyrolactone-I, induces apoptosis with increased Bax/Bcl-2 ratio in p53-mutated pancreatic cancer cells.

Wada M, Hosotani R, Lee JU, Doi R, Koshiba T, Fujimoto K, Miyamoto Y, Tsuji S, Nakajima S, Okuyama A, Imamura M. Wada M, et al. Among authors: hosotani r. Anticancer Res. 1998 Jul-Aug;18(4A):2559-66. Anticancer Res. 1998. PMID: 9703910

9

Expression of two angiogenic factors, vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer, and its relationship to angiogenesis.

Fujimoto K, Hosotani R, Wada M, Lee JU, Koshiba T, Miyamoto Y, Tsuji S, Nakajima S, Doi R, Imamura M. Fujimoto K, et al. Among authors: hosotani r. Eur J Cancer. 1998 Aug;34(9):1439-47. doi: 10.1016/s0959-8049(98)00069-0. Eur J Cancer. 1998. PMID: 9849429

10

Auto-induction and growth stimulatory effect of betacellulin in human pancreatic cancer cells.

Kawaguchi M, Hosotani R, Kogire M, Ida J, Doi R, Koshiba T, Miyamoto Y, Tsuji S, Nakajima S, Kobayashi H, Masui T, Imamura M. Kawaguchi M, et al. Among authors: hosotani r. Int J Oncol. 2000 Jan;16(1):37-41. Int J Oncol. 2000. PMID: 10601546

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters